Jaguar Health Files 8-K: Corporate Updates

Ticker: JAGX · Form: 8-K · Filed: 2025-08-19T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, financial-reporting, regulatory-filing

Related Tickers: JAGX

TL;DR

Jaguar Health dropped an 8-K with votes, Reg FD, and financials - check it out.

AI Summary

On August 19, 2025, Jaguar Health, Inc. filed an 8-K report detailing matters submitted to a vote of security holders, Regulation FD disclosures, and financial statements and exhibits. The filing pertains to the company's operations and corporate governance.

Why It Matters

This 8-K filing provides important updates on Jaguar Health's corporate actions and financial reporting, which are crucial for investors to understand the company's current status and governance.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse events.

Key Players & Entities

FAQ

What are the main items reported in this 8-K filing by Jaguar Health, Inc.?

The 8-K filing reports on matters submitted to a vote of security holders, Regulation FD disclosures, and financial statements and exhibits.

When was the report filed and what is the earliest event date reported?

The report was filed on August 19, 2025, and the earliest event date reported is also August 19, 2025.

What is Jaguar Health, Inc.'s state of incorporation and commission file number?

Jaguar Health, Inc. is incorporated in Delaware and its commission file number is 001-36714.

What is the business address and phone number for Jaguar Health, Inc.?

The business address is 200 Pine Street, Suite 400, San Francisco, California 94104, and the phone number is (415) 371-8300.

What was the former name of Jaguar Health, Inc. and when did the name change occur?

The former name was Jaguar Animal Health, Inc., and the date of the name change was August 30, 2013.

Filing Stats: 1,006 words · 4 min read · ~3 pages · Grade level 11.2 · Accepted 2025-08-19 16:25:28

Key Financial Figures

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated August 19, 2025. 104 Cover Page Interactive Data File (embedded with the inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JAGUAR HEALTH, INC. By: /s/ Lisa A. Conte Name: Lisa A. Conte Title: Chief Executive Officer & President Date: August 19, 2025

View on Read The Filing